About this trial
This study aims to evaluate the effects of moderate-to-high intensity aerobic exercise on primary dysmenorrhea, a common condition characterized by painful menstrual cramps.
The study will involve women diagnosed with primary dysmenorrhea, who will be randomly assigned to one of two groups:
Experimental Group: Participants will perform a supervised aerobic exercise program tailored to their fitness level.
Control Group: Participants will continue their usual care without any additional interventions.
The study will run from February 2025 to April 2025 in Madrid, Spain. Before starting, all participants will complete a questionnaire to gather information about their demographics, menstrual cycle characteristics, medical history, and physical activity levels. This will help ensure an accurate diagnosis of primary dysmenorrhea and provide baseline data for comparison.
Participants will be randomly assigned to their groups using a computer-generated sequence, with allocation managed confidentially to avoid bias. The study's single-blind design ensures that the evaluators will not know the group assignments.
The goal of this research is to determine whether regular aerobic exercise can serve as an effective, non-pharmacological intervention to reduce the severity of menstrual pain and improve the quality of life for women with primary dysmenorrhea. The findings will inform patients, families, and healthcare providers about potential lifestyle strategies to manage this condition.
Eligibility criteria
Qualifiers
Age between 18 and 26 years.
Sedentary lifestyle.
Body Mass Index (BMI) between 18.5 and 26 kg/m².
Regular menstrual cycle (24-38 days).
Disqualifiers
Pregnancy or breastfeeding within the last 3 months.
Amenorrhea.
Use of oral contraceptives in the last 3 months.
Presence of an intrauterine device (IUD).
Trial design
Treatments tested in this trial
- Exercise